Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

Completed · Phase 4

Conditions studied: Inflammation

In brief

The purpose of the study is to test whether atorvastatin (also known as Lipitor) has anti-inflammatory effects in people with no known heart disease or high cholesterol. We also are investigating whether or not genetic differences between people plays a role in the drug response.

Key facts

Study ID

NCT00361283

Run by

University of Florida

People needed

108

Starts

2004-06-01

Expected to finish

2009-01-01

Last updated by the study team

2012-05-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18+ years old
• Normocholesterolemic

You may not qualify if…

• Cardiovascular disease or risk equivalents
• Malignancy
• Active alcohol abuse
• Contraindications to statins
• Interacting drugs
• Chronic anti-inflammatory drugs

Where it is running

• University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.